News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Vivek Subbiah: Our latest commentary on Pediatric AML Trials
Vivek Subbiah/LinkedIn
Jan 29, 2025, 18:53

Vivek Subbiah: Our latest commentary on Pediatric AML Trials

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on LinkedIn about recent paper by Vivek Subbiah and Branko Cuglievan, titled “Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncology” published on Nature Reviews.

Vivek Subbiah: Our latest commentary on Pediatric AML Trials

“Hot of the press.
Pleased to share our latest commentary in Nature Reviews Clinical Oncology. ‘Transforming Pediatric AML Trials: From Failing One-Size-Fits-All Methods to Precision Oncology.’ Thrilled to collaborate with my amazing colleague and friend and the brilliant Dr. Branko Cuglievan.”

Branko Cuglievan cancer Nature Reviews Clinical Oncology OncoDaily Oncology Pediatric AML Trials Vivek Subbiah
Special Coverage
Science
Jan 29, 2025, 18:53
Vivek Subbiah: Our latest commentary on Pediatric AML Trials
Blog
Jan 29, 2025, 18:50
Meet the speakers of the 9th Annual ELLOK Conference
Blog
Jan 29, 2025, 18:47
Douglas Flora: Tackling the "impossible" at the ACS Volunteer Leadership Retreat
Blog
Jan 29, 2025, 18:41
Siobhan Freeney: Why Women need to be fully informed about their Personal Breast Density
Blog
Jan 29, 2025, 18:38
Sendurai Mani: Targeting CD38 to stop aggressive breast cancer and boost the immune system
Career
Jan 29, 2025, 18:32
Karen H. Vousden - Candidate for the Nominating Committee of AACR
Stories
Jan 29, 2025, 18:25
The Mel Mann Story: From Terminal Cancer to 30 Year Survivor
Blog
Jan 29, 2025, 18:18
LPWO - a global initiative empowering women oncologists from nine C/Can cities - City Cancer Challenge
Science
Jan 29, 2025, 18:14
Charles Gaulin: Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma
Blog
Jan 29, 2025, 18:10
January highlights from the ESMO portfolio - Elsevier Oncology
Blog
Jan 29, 2025, 18:07
The addition of pembrolizumab to neoadjuvant chemotherapy in the phase III KEYNOTE-756 - European Society for Medical Oncology
Insight
Jan 29, 2025, 17:41
FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment